Skip to main content

Table 4 Resource utilization among ICU patients (n = 15,014) with and without new-onset atrial fibrillation (NOAF)

From: New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults—a multicenter retrospective cohort study

CharacteristicNew-onset atrial fibrillation (n = 1541)No atrial fibrillation (n = 13,473)P value
Invasive mechanical ventilation, n (%)843 (54.7)7119 (52.8)0.16
Invasive mechanical ventilation days, median (IQR)5 (3–6)5 (2–7)0.37
Non-invasive mechanical ventilation, n (%)256 (16.6)2358 (17.5)0.38
Non-invasive mechanical ventilation days, median (IQR)1 (1–2)1 (1–2)0.15
Vasoactive medication, n (%)991 (64.3)8245 (61.2)0.02
Vasoactive medication days, median (IQR)5 (3–9)5 (2–10)0.11
Arterial line, n (%)915 (59.4)8407 (62.4)0.02
Arterial line days, median (IQR)5 (4–10)5 (4–9)0.36
Renal replacement therapy, n (%)304 (19.7)2411 (17.9)0.18
Renal replacement therapy days, median (IQR)4 (2–9)4 (2–9)0.57
NEMS/day, mean (SD)26.3 (7.2)25.1 (8.0)0.35
Transfusion products, n (%)
 Packed red blood cells592 (38.4)5079 (37.7)0.58
 Platelets104 (6.7)688 (5.1)< 0.01
 Fresh frozen plasma85 (5.5)835 (6.2)0.29
 Albumin735 (47.7)6898 (51.2)< 0.01
Treatment strategy, n (%)
 Beta-blocker, calcium channel blocker, or digoxin644 (41.8) 
 Antiarrhythmic747 (48.5) 
 Electrical cardioversion22 (1.4) 
 Combination128 (8.3) 
  1. Abbreviations: IQR interquartile range, NEMS Nine Equivalents of Nursing Manpower Scale, SD standard deviation